Recombinant Human WW domain-containing oxidoreductase (WWOX)

Code CSB-YP873704HU
MSDS
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP873704HU
MSDS
Size Pls inquire
Source E.coli
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP873704HU-B
MSDS
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP873704HU
MSDS
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP873704HU
MSDS
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
WWOX
Uniprot No.
Alternative Names
5330426P09Rik; 9030416C10Rik; Aberrant WW domain-containing oxidoreductase; D16S432E; EC 1.1.1.-; EIEE28; FOR; FRA16D; Fragile site FRA16D oxidoreductase; Fragile site FRA16D Oxireductase; HHCMA56; MGC55975; PRO0128; Putative oxidoreductase; SCAR12; SDR41C1; Short chain dehydrogenase/reductase family 41C, member 1; WOX1; WW domain containing oxidoreductase; WW domain-containing oxidoreductase; WW domain-containing protein WWOX; wwox; WWOX_HUMAN; zgc:55975
Species
Homo sapiens (Human)
Expression Region
1-414
Target Protein Sequence
MAALRYAGLD DTDSEDELPP GWEERTTKDG WVYYANHTEE KTQWEHPKTG KRKRVAGDLP YGWEQETDEN GQVFFVDHIN KRTTYLDPRL AFTVDDNPTK PTTRQRYDGS TTAMEILQGR DFTGKVVVVT GANSGIGFET AKSFALHGAH VILACRNMAR ASEAVSRILE EWHKAKVEAM TLDLALLRSV QHFAEAFKAK NVPLHVLVCN AATFALPWSL TKDGLETTFQ VNHLGHFYLV QLLQDVLCRS APARVIVVSS ESHRFTDIND SLGKLDFSRL SPTKNDYWAM LAYNRSKLCN ILFSNELHRR LSPRGVTSNA VHPGNMMYSN IHRSWWVYTL LFTLARPFTK SMQQGAATTV YCAAVPELEG LGGMYFNNCC RCMPSPEAQS EETARTLWAL SERLIQERLG SQSG
Protein Length
full length protein
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development. May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm.
Gene References into Functions
  1. We have identified a variant in WWOX and in lncRNA RP11-679B19.1 as a diseasemodifying genetic variant associated with recurrent fibrostenotic CD PMID: 29361163
  2. A model is supported in which FRA16D common fragile sites are sequences that may initiate replication in early-mid S phase but are slow to complete replication, and the chromosomal breaks and gaps observed in metaphase cells result from unreplicated DNA. PMID: 14603443
  3. Data conclude that WWOX sensitises EOC to paclitaxel via ER stress-induced apoptosis, and predicts clinical outcome in patients. Thus, ER stress response mechanisms could be targeted to overcome chemoresistance in cancer. PMID: 28749468
  4. Data show that patients with advanced-stage oral cancer were associated with a higher frequency of WWOX rs11545028 polymorphisms with the variant genotype TT than did patients with the wild-type gene. PMID: 27655721
  5. WWOX expression was strongly inhibited in human lung cancers and lung cancer cell lines. Reintroducing WWOX into lung cancer cells inhibited their invasive phenotype through downregulating RUNX2 and its target genes including MMP-9 expression. PMID: 27834355
  6. Our data suggests that the deletion genotypes of CNV-67048 in WWOX predispose their carriers to intracranial aneurysms PMID: 26910372
  7. It has been proposed that Fhit and Wwox loss work synergistically in cancer progression and that DNA damage caused by Fhit could be targeted early in cancer initiation for prevention, while DNA damage caused by Wwox loss could be targeted later in cancer progression, particularly in cancers that develop resistance to genotoxic therapies. (Review) PMID: 27773744
  8. genetic variations in WWOX may be a significant predictor of early HCC occurrence and a reliable biomarker for disease progression PMID: 28426730
  9. a WWOX-p53 network regulates normal bone formation and that disruption of this network in osteoprogenitors results in accelerated osteosarcoma. PMID: 27550453
  10. Low WWOX expression is associated with Head and Neck Squamous Cell Carcinoma. PMID: 27501229
  11. Knockdown of lung WWOX expression in mice was observed to cause neutrophil influx and was accompanied by a corresponding vascular leak and inflammatory cytokine production. In cultured human alveolar epithelial cells, loss of WWOX expression resulted in increased c-Jun- and IL-8-dependent neutrophil chemotaxis toward cell monolayers. PMID: 28283473
  12. a portion of ERK and WWOX relocates to the nucleus, suggesting their role in the induction of CD3 and CD8 expression in MOLT-4. PMID: 27339895
  13. Brca1-Wwox interaction supports non-homologous end-joining as the dominant DSB repair pathway in Wwox-sufficient cells PMID: 27869163
  14. Epigenetic mechanisms influence molecular patterns important for the bone-metastatic process, and this review highlights the role of WW-domain containing oxidoreductase (Wwox). [review] PMID: 28045433
  15. the deregulation of microRNA-214-3p expression is involved in a negative feedback loop with WWOX in osteosarcoma, indicating that miR-214-3p has potential basic and clinical implications. PMID: 27840941
  16. Functional analyses further showed a lower mRNA level of WWOX in tissues with the 0-copy or 1-copy than that in those with the 2-copy (P = 0.045). Our data suggested the CNV-67048 to be a risk factor of epithelia ovarian cancer in Chinese women. PMID: 27190995
  17. WW domain-containing oxidoreductase overexpression promoted apoptosis in 5637 cells and resulted in upregulation of Bax, downregulation of Bcl-2, and elevated levels of cleaved caspase-3 and cleaved PARP, indicating activation of the intrinsic apoptosis pathway. PMID: 27352332
  18. The SNP rs383362G >T of WWOX plays a role in chronic obstructive pulmonary disease inheritance. PMID: 26902998
  19. a novel SNP in the intron of the WW domain-containing oxidoreductase (WWOX) gene yielded significant replicated associations with skin tanning ability PMID: 26174610
  20. WWOX mutation is associated with early infantile epileptic encephalopathy. PMID: 26345274
  21. Our data suggest that the loss genotypes of CNV-67048 in WWOX predispose their carriers to chronic obstructive pulmonary disease. PMID: 25517572
  22. WWOX played roles in metabolic regulation and controlling central nervous system development. [review] PMID: 26499798
  23. Data suggest that Pc2- (polycomb repressive complex 2-) mediated SUMOylation of WWOX is essential for suppressive activity of WWOX in prostate cancer tumorigenesis. PMID: 26592150
  24. Compared to the controls, upregulation of WWOX and its Tyr33 phosphorylation was observed in the head region of all pterygium specimens. In the head and body of the pterygium specimens, WWOX expression was significantly higher than in the controls. PMID: 26120275
  25. Down regulation of WWOX is involved in tumorigenesis in intrahepatic cholangiocarcinoma. PMID: 25168293
  26. Decreased WWOX expression may interfere with gemcitabine sensitivity, and allele-specific binding at rs11644332 might be a causative molecular mechanism behind the clinically observed associations. PMID: 26857392
  27. Hypermethylation of WWOX gene is associated with Epstein-Barr virus-associated gastric carcinomas. PMID: 25720522
  28. The WWOX gene can downregulate the expression levels of cell cycle proteins cyclin E-CDK2 and cyclin D1-CDK4, which affects the cell cycle of ovarian cancer stem cells. PMID: 25891642
  29. The inhibition of the transcriptional activity of BCL9-2 by WWOX and HDAC3 constitutes a new molecular mechanism and provides new insight for a broad range of cancers. PMID: 25678599
  30. Results suggest that WWOX gene plays a role in the regulation of epithelial to mesenchymal transition process in endometrial cancer by controlling the expression of proteins associated with cell motility and suppressing mesenchymal markers. PMID: 25892250
  31. HGF and TGFbeta1 of bone-metastasis microenvironment acted co-ordinately, influencing non redundant pathways regulated by Twist program or Snail-transcription factor, with reversible MET switch PMID: 26041563
  32. miR-153 inhibited protein level of WWOX, a tumor suppressor and inhibitor of beta-catenin signaling, through targeting its 3'-untranslated region. PMID: 25708809
  33. WWOX inhibits prostate cancer progression through negatively regulating cyclin D1 in cell cycle lead to G1 arrest. PMID: 25659037
  34. overexpression of WWOX attenuated miR-134 induced H69 small cell lung cancer cell growth, and promoted cell apoptosis PMID: 26166818
  35. Study underscores a key role of allosteric communication in the ability of the WW2 orphan domain to chaperone physiological action of the WW1 domain within the context of the WW1-WW2 tandem module of WWOX. PMID: 25703206
  36. Inactivation of WWOX gene contributes to the progression of head and neck squamous cell carcinoma. PMID: 25612104
  37. A strong genetic cosegregation between the WWOX gene and the low HDL-C trait observed genetic associations at the chr16q23-24 locus. PMID: 24871327
  38. The role of WWOX in EHCC progression. PMID: 25502636
  39. WWOX undoubtedly incriminated as a gene for recessive infantile epileptic encephalopathy. PMID: 25411445
  40. There are roles of WWOX in the pathogenesis and endocrine therapy of breast cancer. PMID: 25476151
  41. WWOX structure gives insights into the functional versatility of this key signaling protein with important implications on its biology. PMID: 25662954
  42. Two and more tandem repeats cooperate in binding to their targets, in the well-characterized family of WWOX domains and their corresponding polyproline ligands. PMID: 25710931
  43. WWOX plays a role in the development, signaling pathway, prognosis, and treatment response of malignant glioma. PMID: 25432984
  44. WWOX is a member of a very interesting family of very large common fragile site genes and functions as a tumor suppressor involved in the development of many cancers. PMID: 25595185
  45. Aberrant WWOX expression contributes to the altered metabolism in cancer. PMID: 25595186
  46. WWOX can be regarded as a prognostic marker and a candidate molecule for targeted cancer therapies. PMID: 25595191
  47. WWOX plays a critical role in normal central nervous system development and disease. PMID: 25416187
  48. WWOX is a tumor suppressor gene and is associated with FRA16D locus fragility. PMID: 25538133
  49. WWOX has many functions, and its deletion affects cellular metabolism and neoplastic progression. PMID: 25491415
  50. WWOX gene is located in FRA16D, the highly affected chromosomal fragile site. PMID: 25681467

Show More

Hide All

Involvement in disease
Esophageal cancer (ESCR); Spinocerebellar ataxia, autosomal recessive, 12 (SCAR12); Epileptic encephalopathy, early infantile, 28 (EIEE28)
Subcellular Location
Cytoplasm. Nucleus. Mitochondrion. Golgi apparatus.
Protein Families
Short-chain dehydrogenases/reductases (SDR) family
Tissue Specificity
Widely expressed. Strongly expressed in testis, prostate, and ovary. Overexpressed in cancer cell lines. Isoform 5 and isoform 6 may only be expressed in tumor cell lines.
Database Links

HGNC: 12799

OMIM: 133239

KEGG: hsa:51741

STRING: 9606.ENSP00000457230

UniGene: Hs.461453

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1